KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) FCF Margin (2018 - 2026)

ClearPoint Neuro's FCF Margin history spans 13 years, with the latest figure at 116.95% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 9757.0% to 116.95% in Q4 2025 year-over-year; TTM through Dec 2025 was 66.12%, a 3674.0% decrease, with the full-year FY2025 number at 66.12%, down 3674.0% from a year prior.
  • FCF Margin hit 116.95% in Q4 2025 for ClearPoint Neuro, down from 36.96% in the prior quarter.
  • Over the last five years, FCF Margin for CLPT hit a ceiling of 14.91% in Q3 2024 and a floor of 116.95% in Q4 2025.
  • Historically, FCF Margin has averaged 63.33% across 5 years, with a median of 67.39% in 2021.
  • Biggest five-year swings in FCF Margin: surged 5682bps in 2024 and later tumbled -9757bps in 2025.
  • Tracing CLPT's FCF Margin over 5 years: stood at 83.84% in 2021, then rose by 28bps to 59.99% in 2022, then soared by 71bps to 17.47% in 2023, then decreased by -11bps to 19.38% in 2024, then plummeted by -503bps to 116.95% in 2025.
  • Business Quant data shows FCF Margin for CLPT at 116.95% in Q4 2025, 36.96% in Q3 2025, and 28.68% in Q2 2025.